Sanara MedTech Inc. (SMTI)

[Mean Weimaraner]

The following statements made in the promotional materials, that the Company has two FDA cleared products including the release of its new bone hemostat product, HemaQuell™ Resorbable Bone Hemostat, approximately 220% growth over the past three years, 63% growth in sales from 2015 to 2016, a growing internal sales management team, and a network of seasoned healthcare distributors, are materially true.